Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2025)
Tectonic Therapeutic's (TECX) quarterly Retained Earnings came in at $474.2 million in Q4 2025, up 5268344.44% year-on-year from N/an in Q4 2024, and up 333.0% on a QoQ basis from -$203.5 million in Q3 2025.
Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2025) Analysis & Trends
Tectonic Therapeutic (TECX) has 9 years of Retained Earnings data on file, last reported at $474.2 million in Q4 2025.
- On a quarterly basis, Retained Earnings rose 5268344.44% year-over-year to $474.2 million in Q4 2025; TTM through Dec 2025 was $474.2 million, a 5268344.44% increase from a year earlier, with the FY2025 full-year figure at $474.2 million, up 5268344.44% from the prior year.
- Retained Earnings for Q4 2025 stood at $474.2 million, up from -$203.5 million in the prior quarter.
- Over the last five years, Retained Earnings for TECX reached as high as $474.2 million in Q4 2025 and fell as low as -$514.4 million in Q1 2023.
- Historically, Retained Earnings has averaged -$243.1 million across 5 years, with a median of -$339.0 million in 2021.
- On a YoY basis, Retained Earnings climbed as much as 5268344.44% in 2025 and fell as far as 264185.71% in 2025.
- Year by year, Retained Earnings stood at -$383.5 million in 2021, then retreated by 27.61% to -$489.4 million in 2022, then soared by 101.22% to $6.0 million in 2023, then tumbled by 99.85% to $9000.0 in 2024, then soared by 5268344.44% to $474.2 million in 2025.
- Per Business Quant data, the three most recent Retained Earnings figures were $474.2 million in Q4 2025, -$203.5 million in Q3 2025, and -$184.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 474.16 Mn |
| Sep 30, 2025 | -203.50 Mn |
| Jun 30, 2025 | -184.50 Mn |
| Mar 31, 2025 | -164.49 Mn |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Jun 30, 2024 | 284.92 Mn |
| Mar 31, 2024 | -484.08 Mn |
| Dec 31, 2023 | 5.98 Mn |
| Sep 30, 2023 | -468.49 Mn |
| Jun 30, 2023 | -446.91 Mn |
| Mar 31, 2023 | -514.39 Mn |
| Dec 31, 2022 | -489.43 Mn |
| Sep 30, 2022 | -464.40 Mn |
| Jun 30, 2022 | -441.43 Mn |
| Mar 31, 2022 | -413.38 Mn |
| Dec 31, 2021 | -383.54 Mn |
| Sep 30, 2021 | -355.32 Mn |
| Jun 30, 2021 | -322.70 Mn |
| Mar 31, 2021 | -291.32 Mn |